Cspc Zhongqi Pharmaceutical Technology Co., Ltd.
Clinical trials sponsored by Cspc Zhongqi Pharmaceutical Technology Co., Ltd., explained in plain language.
A Chinese pharmaceutical company, subsidiary of CSPC Pharmaceutical Group.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Breakfast or not? study tests Food's impact on new pill
Knowledge-focused CompletedThis completed Phase 1 trial tested how a high-fat or low-fat meal changes the way the body absorbs ammoxetine, a potential antidepressant. Eighteen healthy adults each took a single 60 mg dose under three different meal conditions. The goal was to see if food affects drug levels…
Phase: PHASE1 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Healthy volunteers help uncover Food-Drug interactions
Knowledge-focused CompletedThis study looked at how taking ammoxetine tablets with or without food changes the drug levels in the body. Fourteen healthy adults participated in a two-period crossover design. The goal was to understand food's impact on drug absorption to guide future dosing recommendations.
Phase: PHASE1 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC